Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： M A,Siciliano

第一单位： Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy.

作者： M A,Siciliano ^[1] ; G,Caridà ^[1] ; D,Ciliberto ^[2] ; M,d'Apolito ^[1] ; C,Pelaia ^[1] ; D,Caracciolo ^[1] ; C,Riillo ^[1] ; P,Correale ^[3] ; A,Galvano ^[4] ; A,Russo ^[4] ; V,Barbieri ^[5] ; P,Tassone ^[1] ; P,Tagliaferri ^[6]

作者单位： Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy. ^[1] Mater Domini University Hospital, Catanzaro, Italy. ^[2] Unit of Medical Oncology, Oncology Department, Grand Metropolitan Hospital 'Bianchi Melacrino-Morelli', Reggio Calabria, Italy. ^[3] Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo University Hospital, Palermo, Italy. ^[4] Unit of Medical Oncology, Oncology Department, 'Pugliese-Ciaccio' Hospital, Catanzaro, Italy. ^[5] Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy. Electronic address: tagliaferri@unicz.it. ^[6]

关键词 checkpoints inhibitors frontline therapy network meta-analysis non-small-cell lung cancer systematic review

主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms)

DOI 10.1016/j.esmoop.2022.100465

PMID 35427835

发布时间 2022-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

ESMO open

2022年7卷3期

100465页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.

ESMO open

相似文献

ESMO open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.

ESMO open

相似文献

ESMO open

相关期刊

检索历史清除